List of insiders holdings for BIOCRYST PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
2 | BAKER FELIX Baker Bros. Investments II L.P. Baker/Tisch Investments LP 667 L.P. Baker Brothers Life Sciences LP 14159 L.P. BAKER BROS. ADVISORS LP BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Bros. Investments L.P. 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
3 | Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
4 | Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
5 | Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
6 | Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2015-02-17 16:28:27 | 10,713,686 0 |
10,713,686 | Form 13G |
7 | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2024-02-14 16:21:51 | 10,204,089 0 |
10,204,089 | Form 13G |
8 | Stonehouse Jon P President & CEO |
2024-12-23 16:01:43 | 2,179,359 30,000 |
2,209,359 | Form 4 |
9 | Gayer Charles K Chief Commercial Officer |
2024-12-23 16:19:15 | 684,496 0 |
684,496 | Form 4 |
10 | Barnes Alane P Chief Legal Officer |
2024-12-23 16:05:25 | 662,829 0 |
662,829 | Form 4 |
11 | Doyle Anthony Chief Financial Officer |
2024-12-23 16:11:24 | 627,967 0 |
627,967 | Form 4 |
12 | Thackray Helen M. Chief R&D Officer |
2025-04-02 16:18:50 | 377,318 0 |
377,318 | Form 4 |
13 | Babu Yarlagadda S Chief Discovery Officer |
2022-11-16 16:19:59 | 298,541 0 |
298,541 | Form 4 |
14 | Powell Lynne Senior VP - CCO |
2019-01-29 16:21:51 | 246,281 0 |
246,281 | Form 4 |
15 | Grant Stuart SR VP & CFO |
2011-03-18 16:49:38 | 238,740 0 |
238,740 | Form 4 |
16 | Sniecinski Megan Chief Business Officer |
2020-12-17 16:45:24 | 225,000 0 |
225,000 | Form 4 |
17 | ASELAGE STEVE Director |
2024-06-14 16:20:58 | 120,092 2,500 |
122,592 | Form 4 |
18 | Galson Steven K Director |
2024-06-14 16:23:04 | 86,364 21,940 |
108,304 | Form 4 |
19 | LEE KENNETH B JR Director |
2023-06-15 16:42:19 | 107,935 0 |
107,935 | Form 4 |
20 | HEGGIE THERESA Director |
2024-06-14 16:25:16 | 102,785 0 |
102,785 | Form 4 |
21 | LEVIN ALAN G Director |
2024-06-14 16:28:46 | 101,704 0 |
101,704 | Form 4 |
22 | INGRAM ROBERT ALEXANDER Director |
2023-03-02 16:41:35 | 100,198 0 |
100,198 | Form 4 |
23 | Hutson Nancy J Director |
2024-12-16 16:35:50 | 86,638 0 |
86,638 | Form 4 |
24 | ABERCROMBIE GEORGE B Director |
2024-06-14 16:18:57 | 86,364 0 |
86,364 | Form 4 |
25 | MILANO VINCENT Director |
2025-03-04 16:18:46 | 76,737 0 |
76,737 | Form 4 |
26 | MONTGOMERY JOHN A Director |
2003-11-05 11:47:58 | 46,785 9,800 |
56,585 | Form 4 |
27 | Erck Stanley C Director |
2018-11-30 16:02:47 | 48,333 0 |
48,333 | Form 4 |
28 | Sheridan William P Chief Medical Officer |
2022-03-14 16:21:25 | 37,954 0 |
37,954 | Form 4 |
29 | LOWREY ROBERT S Controller, PAO |
2012-03-29 19:28:15 | 35,000 0 |
35,000 | Form 4 |
30 | Patel Sanj K Director |
2017-05-25 11:57:29 | 30,000 0 |
30,000 | Form 4 |
31 | Cohen Fred E Director |
2018-06-22 09:29:36 | 30,000 0 |
30,000 | Form 4 |
32 | McKee Amy E Director |
2024-06-25 16:39:56 | 27,831 0 |
27,831 | Form 4 |
33 | SANDERS MACHELLE Director |
2024-06-17 16:31:05 | 27,742 0 |
27,742 | Form 4 |
34 | Jones Michael L Exec. Director, Finance - PAO |
2022-12-21 16:36:30 | 25,153 0 |
25,153 | Form 4 |
35 | McCullough David VP |
2012-03-19 13:12:21 | 24,124 0 |
24,124 | Form 4 |
36 | RIGGS RANDALL B Senior VP Business Development |
2007-05-18 12:04:07 | 23,868 0 |
23,868 | Form 4 |
37 | STAAB THOMAS R II Senior Vice President and CFO |
2020-02-25 16:28:09 | 18,000 0 |
18,000 | Form 4 |
38 | BENNETT J CLAUDE Chief Operating Officer |
2008-03-18 16:41:17 | 17,000 0 |
17,000 | Form 4 |
39 | STEER RANDOLPH C Director |
2008-05-23 11:50:47 | 15,000 0 |
15,000 | Form 4 |
40 | Jensen Peder Director |
2014-05-06 15:13:15 | 15,000 0 |
15,000 | Form 4 |
41 | SHERRILL JOSEPH H JR Director |
2007-05-17 18:27:00 | 15,000 0 |
15,000 | Form 4 |
42 | SPENCER WILLIAM M III Director |
2007-05-17 18:20:30 | 15,000 0 |
15,000 | Form 4 |
43 | GORDON CARL L Director |
2006-05-18 15:43:29 | 15,000 0 |
15,000 | Form 4 |
44 | SEIDENBERG BETH C Director |
2010-05-17 14:39:13 | 15,000 0 |
15,000 | Form 4 |
45 | FEATHERINGILL WILLIAM W Director 10% Owner |
2010-05-17 14:53:40 | 15,000 0 |
15,000 | Form 4 |
46 | Biggar Stephen R Director |
2011-05-16 18:15:42 | 15,000 0 |
15,000 | Form 4 |
47 | HOROVITZ ZOLA P Director |
2012-05-24 17:28:05 | 15,000 0 |
15,000 | Form 4 |
48 | HIGGINS JOHN L Director |
2012-05-25 10:19:34 | 15,000 0 |
15,000 | Form 4 |
49 | SANDERS CHARLES A Director |
2016-03-01 16:08:04 | 12,971 0 |
12,971 | Form 4 |
50 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner |
2003-12-11 11:56:48 | 9,600 0 |
9,600 | Form 13G |
51 | Mills Mike Principal Accounting Officer |
2010-03-12 16:34:17 | 4,500 0 |
4,500 | Form 4 |
52 | ALEXANDER W JAMES SR. VP, Chief Medical Officer |
2007-08-02 17:28:15 | 3,659 0 |
3,659 | Form 4 |
53 | BUGG CHARLES E Director |
2007-03-22 18:19:19 | 3,333 0 |
3,333 | Form 4 |
54 | DARWIN MICHAEL A Principal Accounting Officer |
2008-08-04 18:22:12 | 3,048 0 |
3,048 | Form 4 |
55 | Nugent Jonathan M VP Corp Communications |
2007-08-02 17:37:03 | 508 0 |
508 | Form 4 |